These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 9570686)

  • 1. Soluble molecules as biological markers in Hodgkin's disease.
    Nadali G; Vinante F; Chilosi M; Pizzolo G
    Leuk Lymphoma; 1997 Dec; 26 Suppl 1():99-105. PubMed ID: 9570686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble ICAM-1 in Hodgkin's disease: a promising independent predictive marker for survival.
    Christiansen I; Enblad G; Kälkner KM; Gidlöf C; Glimelius B; Tötterman TH
    Leuk Lymphoma; 1995 Oct; 19(3-4):243-51. PubMed ID: 8535215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble CD8, CD25 and CD30 antigens as prognostic markers in patients with untreated Hodgkin's lymphoma.
    Gause A; Jung W; Schmits R; Tschiersch A; Scholz R; Pohl C; Hasenclever D; Diehl V; Pfreundschuh M
    Ann Oncol; 1992 Sep; 3 Suppl 4():49-52. PubMed ID: 1333270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble interleukin-2 receptor, soluble CD8 and soluble intercellular adhesion molecule-1 levels in hematologic malignancies.
    Srivastava MD; Srivastava A; Srivastava BI
    Leuk Lymphoma; 1994 Jan; 12(3-4):241-51. PubMed ID: 7909467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological markers may add to prediction of outcome achieved by the International Prognostic Score in Hodgkin's disease.
    Axdorph U; Sjöberg J; Grimfors G; Landgren O; Porwit-MacDonald A; Björkholm M
    Ann Oncol; 2000 Nov; 11(11):1405-11. PubMed ID: 11142480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum level of the soluble form of the CD30 molecule identifies patients with Hodgkin's disease at high risk of unfavorable outcome.
    Nadali G; Tavecchia L; Zanolin E; Bonfante V; Viviani S; Camerini E; Musto P; Di Renzo N; Carotenuto M; Chilosi M; Krampera M; Pizzolo G
    Blood; 1998 Apr; 91(8):3011-6. PubMed ID: 9531614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical significance of cytokines and soluble forms of membrane-derived activation antigens in the serum of patients with Hodgkin's disease.
    Gause A; Jung W; Keymis S; Schobert I; Scholz R; Schmits R; Diehl V; Pohl C; Hasenclever D; Pfreundschuh M
    Leuk Lymphoma; 1992 Aug; 7(5-6):439-47. PubMed ID: 1283546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Differential diagnostic and prognostic value of serum cytokines (soluble CD30, soluble interleukin-2 receptor, interleukin-10 and interleukin-6) in Hodgkin's disease and lymphosarcomas].
    Iaguzhinskaia OE; Lazarev IE; Nikitin EA; Samoĭlova RS; Loginova IV; Gemdzhan EG; Novikov VA; Mamiliaeva ZKh; Pivnik AV
    Ter Arkh; 2001; 73(4):45-51. PubMed ID: 11494447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble vascular cell adhesion molecule-1 (sVCAM-1) is an independent prognostic marker in Hodgkin's disease.
    Christiansen I; Sundström C; Enblad G; Tötterman TH
    Br J Haematol; 1998 Aug; 102(3):701-9. PubMed ID: 9722296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble cytokine levels correlate with the activity and clinical stage of Hodgkin's disease at diagnosis.
    Vener C; Guffanti A; Pomati M; Colombi M; Alietti A; La Targia ML; Bamonti-Catena F; Baldini L
    Leuk Lymphoma; 2000 Apr; 37(3-4):333-9. PubMed ID: 10752984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biopathologic features of Hodgkin's disease.
    Chilosi M; Pizzolo G
    Leuk Lymphoma; 1995 Feb; 16(5-6):385-95. PubMed ID: 7787748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation and prognostic value of serum soluble ICAM-1, beta-2 microglobulin, and IL-2alphaR levels in non-Hodgkin's lymphoma.
    Pérez-Encinas M; Quintas A; Bendaña A; Rabuñal MJ; Bello JL
    Leuk Lymphoma; 1999 May; 33(5-6):551-8. PubMed ID: 10342582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between clinical features and circulating levels of soluble intercellular adhesion molecule-1 in Hodgkin's disease.
    Nadali G; Vinante F; Rigo A; Tecchio C; Morosato L; Zanolin E; Perona G; Chilosi M; Pizzolo G
    Int J Clin Lab Res; 1995; 25(2):84-7. PubMed ID: 7663010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of soluble adhesion molecules in Hodgkin's disease.
    Syrigos KN; Salgami E; Karayiannakis AJ; Katirtzoglou N; Sekara E; Roussou P
    Anticancer Res; 2004; 24(2C):1243-7. PubMed ID: 15154654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum soluble interleukin-2 receptor, beta2-microglobulin, lactate dehydrogenase and erythrocyte sedimentation rate in children with Hodgkin's lymphoma.
    Bien E; Balcerska A
    Scand J Immunol; 2009 Nov; 70(5):490-500. PubMed ID: 19874554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum levels of soluble CD30 molecule (Ki-1 antigen) in Hodgkin's disease: relationship with disease activity and clinical stage.
    Pizzolo G; Vinante F; Chilosi M; Dallenbach F; Josimovic-Alasevic O; Diamantstein T; Stein H
    Br J Haematol; 1990 Jun; 75(2):282-4. PubMed ID: 2164839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum soluble interleukin-2 receptor, soluble CD8 and soluble intercellular adhesion molecule-1 levels in Crohn's disease, celiac disease, and systemic lupus erythematosus.
    Srivastava MD; Rossi TM; Lebenthal E
    Res Commun Mol Pathol Pharmacol; 1995 Jan; 87(1):21-6. PubMed ID: 7735726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of soluble CD30 antigen in the sera of patients with untreated Hodgkin's disease.
    Gause A; Pohl C; Tschiersch A; Da Costa L; Jung W; Diehl V; Hasenclever D; Pfreundschuh M
    Blood; 1991 May; 77(9):1983-8. PubMed ID: 1850308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble CD30: a possible serum tumor marker for primary effusion lymphoma.
    Michai M; Goto H; Hattori S; Vaeteewoottacharn K; Wongkham C; Wongkham S; Okada S
    Asian Pac J Cancer Prev; 2012; 13(10):4939-41. PubMed ID: 23244086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum levels of soluble CD30 are elevated in the majority of untreated patients with Hodgkin's disease and correlate with clinical features and prognosis.
    Nadali G; Vinante F; Ambrosetti A; Todeschini G; Veneri D; Zanotti R; Meneghini V; Ricetti MM; Benedetti F; Vassanelli A
    J Clin Oncol; 1994 Apr; 12(4):793-7. PubMed ID: 8151321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.